0001209191-18-036127.txt : 20180606
0001209191-18-036127.hdr.sgml : 20180606
20180606172805
ACCESSION NUMBER: 0001209191-18-036127
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180604
FILED AS OF DATE: 20180606
DATE AS OF CHANGE: 20180606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirson Eilon D.
CENTRAL INDEX KEY: 0001654356
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18884607
MAIL ADDRESS:
STREET 1: TOPAZ BUILDING, MATAN CENTER
CITY: HAIFA
STATE: L3
ZIP: 31905
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-04
0
0001645113
NovoCure Ltd
NVCR
0001654356
Kirson Eilon D.
C/O NOVOCURE INC.,
VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Science Officer
Ordinary Shares
2018-06-04
4
M
0
218781
7.03
A
258363
D
Ordinary Shares
2018-06-04
4
S
0
225296
28.60
D
33067
D
Ordinary Shares
2018-06-04
4
M
0
59130
7.48
A
92197
D
Ordinary Shares
2018-06-04
4
M
0
68250
7.15
A
160447
D
Ordinary Shares
2018-06-04
4
S
0
114934
29.36
D
45513
D
Ordinary Shares
2018-06-04
4
S
0
1800
30.26
D
43713
D
Ordinary Shares
2018-06-04
4
S
0
4131
31.74
D
39582
D
Options to Buy Ordinary Shares
7.03
2018-06-04
4
M
0
218781
0.00
A
2023-02-19
Ordinary Shares
218781
0
D
Options to Buy Ordinary Shares
7.48
2018-06-04
4
M
0
59130
0.00
A
2024-02-25
Ordinary Shares
59130
0
D
Options to Buy Ordinary Shares
7.15
2018-06-04
4
M
0
68250
0.00
A
2027-02-21
Ordinary Shares
68250
204750
D
On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 225,296 shares in multiple trades at prices ranging from $28.00 to $28.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 114,934 shares in multiple trades at prices ranging from $29.00 to $29.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,800 shares in multiple trades at prices ranging from $30.00 to $30.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 4,131 shares in multiple trades at prices ranging from $31.00 to $31.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Options exercised were fully vested as of the date hereof.
By: /s/ Kimberly Burke, Attorney in fact for Eilon D. Kirson
2018-06-06